Overview

Tolerability of Antistax® in Patients Suffering From Chronic Venous Insufficiency (CVI)

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Main objective: Safety and tolerability of Antistax® film coated tablets Secondary objective: Effect of Antistax® film coated tablets on subjective symptoms of chronic venous insufficiency
Phase:
Phase 4
Details
Lead Sponsor:
Boehringer Ingelheim